Cargando…
Herpes zoster in SLE: prevalence, incidence and risk factors
OBJECTIVES: This study aimed to evaluate the prevalence and incidence of herpes zoster (HZ) events and describe its associated factors in a study of patients with SLE. METHODS: 491 consecutive SLE participants were screened for HZ events using a patient-reported questionnaire to capture outcomes on...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753438/ https://www.ncbi.nlm.nih.gov/pubmed/35017186 http://dx.doi.org/10.1136/lupus-2021-000574 |
_version_ | 1784632096458801152 |
---|---|
author | Kwan, Andrew Rayes, Hanan Al Lazova, Tijana Anderson, Nicole Bonilla, Dennisse Su, Jiandong Touma, Zahi |
author_facet | Kwan, Andrew Rayes, Hanan Al Lazova, Tijana Anderson, Nicole Bonilla, Dennisse Su, Jiandong Touma, Zahi |
author_sort | Kwan, Andrew |
collection | PubMed |
description | OBJECTIVES: This study aimed to evaluate the prevalence and incidence of herpes zoster (HZ) events and describe its associated factors in a study of patients with SLE. METHODS: 491 consecutive SLE participants were screened for HZ events using a patient-reported questionnaire to capture outcomes on pain and other characteristics associated with HZ events. Sociodemographic, clinical and laboratory measures were also analysed, and time-dependent Cox regression survival analyses were performed to investigate factors associated with HZ events. RESULTS: Prevalence of HZ was 30.5%, incidence was 14.3 cases per 1000 person-years. Lymphopenia and glucocorticoid dosing were significantly associated with HZ events. CONCLUSIONS: HZ is highly prevalent in SLE, which may be linked to disease-related and treatment-related effects on cellular immunity. Our results suggest that the presence of certain risk factors may be useful to allow identification of patients at risk of HZ and improve its management in patients with SLE. |
format | Online Article Text |
id | pubmed-8753438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87534382022-01-26 Herpes zoster in SLE: prevalence, incidence and risk factors Kwan, Andrew Rayes, Hanan Al Lazova, Tijana Anderson, Nicole Bonilla, Dennisse Su, Jiandong Touma, Zahi Lupus Sci Med Epidemiology and Outcomes OBJECTIVES: This study aimed to evaluate the prevalence and incidence of herpes zoster (HZ) events and describe its associated factors in a study of patients with SLE. METHODS: 491 consecutive SLE participants were screened for HZ events using a patient-reported questionnaire to capture outcomes on pain and other characteristics associated with HZ events. Sociodemographic, clinical and laboratory measures were also analysed, and time-dependent Cox regression survival analyses were performed to investigate factors associated with HZ events. RESULTS: Prevalence of HZ was 30.5%, incidence was 14.3 cases per 1000 person-years. Lymphopenia and glucocorticoid dosing were significantly associated with HZ events. CONCLUSIONS: HZ is highly prevalent in SLE, which may be linked to disease-related and treatment-related effects on cellular immunity. Our results suggest that the presence of certain risk factors may be useful to allow identification of patients at risk of HZ and improve its management in patients with SLE. BMJ Publishing Group 2022-01-11 /pmc/articles/PMC8753438/ /pubmed/35017186 http://dx.doi.org/10.1136/lupus-2021-000574 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology and Outcomes Kwan, Andrew Rayes, Hanan Al Lazova, Tijana Anderson, Nicole Bonilla, Dennisse Su, Jiandong Touma, Zahi Herpes zoster in SLE: prevalence, incidence and risk factors |
title | Herpes zoster in SLE: prevalence, incidence and risk factors |
title_full | Herpes zoster in SLE: prevalence, incidence and risk factors |
title_fullStr | Herpes zoster in SLE: prevalence, incidence and risk factors |
title_full_unstemmed | Herpes zoster in SLE: prevalence, incidence and risk factors |
title_short | Herpes zoster in SLE: prevalence, incidence and risk factors |
title_sort | herpes zoster in sle: prevalence, incidence and risk factors |
topic | Epidemiology and Outcomes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753438/ https://www.ncbi.nlm.nih.gov/pubmed/35017186 http://dx.doi.org/10.1136/lupus-2021-000574 |
work_keys_str_mv | AT kwanandrew herpeszosterinsleprevalenceincidenceandriskfactors AT rayeshananal herpeszosterinsleprevalenceincidenceandriskfactors AT lazovatijana herpeszosterinsleprevalenceincidenceandriskfactors AT andersonnicole herpeszosterinsleprevalenceincidenceandriskfactors AT bonilladennisse herpeszosterinsleprevalenceincidenceandriskfactors AT sujiandong herpeszosterinsleprevalenceincidenceandriskfactors AT toumazahi herpeszosterinsleprevalenceincidenceandriskfactors |